Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1 21Phase 3 11Phase 1/2 8Phase NA 3Phase 2/3 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 17Recruiting 10Unknown 8Not yet recruiting 8Terminated 4Withdrawn 3Active not recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Paclitaxel × Clear all
NCT02102438 2016-08-31

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Instituto do Cancer do Estado de São Paulo

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT02637375 2016-05-30

A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer

University of Chicago

Phase NA Withdrawn
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01159236 2012-07-31

Molecular Triaging of Newly Diagnosed Breast Cancer

M.D. Anderson Cancer Center

Phase NA Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡